Literature DB >> 26358595

Genome Sequences of Two Multidrug-Resistant Acinetobacter baumannii Clinical Strains Isolated from Southern India.

Veeraraghavan Balaji1, Sangeetha Rajenderan1, Shalini Anandan1, Indranil Biswas2.   

Abstract

Acinetobacter baumannii is an emerging nosocomial pathogen causing infections worldwide. In this study, we determined the genome sequences of two multidrug-resistant A. baumannii clinical strains isolated from a hospital in southern India. Genome analyses indicate that both the strains harbor numerous horizontally transferred genetic elements and antibiotic resistance cassettes.
Copyright © 2015 Balaji et al.

Entities:  

Year:  2015        PMID: 26358595      PMCID: PMC4566177          DOI: 10.1128/genomeA.01010-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Acinetobacter baumannii, a Gram-negative nonfermenting aerobic bacterium, is responsible for a variety of infections, including bacteremia, meningitis, skin and soft tissue infections, and ventilator-associated pneumonia (1). This pathogen has now become a major causative agent of nosocomial infections worldwide due to its extraordinary ability to acquire novel resistance determinants to numerous antimicrobial compounds (2). The carbapenems are generally used for the treatment of infections caused by multidrug-resistant (MDR) A. baumannii; however, in recent years, carbapenem-resistant A. baumannii bacteria are also on the rise. In this report, we determined the draft genomes of MDR A. baumannii clinical isolates harboring New Delhi metallo-β-lactamase (NDM) determinants. The first strain, B11911, was isolated from a patient with bloodstream infection, while the second strain, SP1917, was isolated from a patient with ventilator-associated pneumonia. The B11911 and SP1917 strains were sequenced using P6/R4 chemistry in the PacBio RS II sequencing platform. The sequencing generated 30,578 reads with a mean length of 10,896 bp for B11911 and 17,292 reads with a mean length of 9,742 bp for SP1917 from a single SMRT cell. The sequences were assembled de novo with Hierarchical Genome Assembly Process 3 (HGAP3; SMRTAnalysis, version 2.3.0) (3, 4), and the contigs were trimmed with Minimus 2 (5). The draft genome of B11911 consists of 4 contigs encompassing a total of 4,263,915-bp sequence with an N50 contig size of 4,018,724 bp. The genome assembly suggests the presence of one chromosome (trimmed) and one plasmid (trimmed), and a portion of a small plasmid (untrimmed) in the B11911 genome. The draft genome of SP1917 consists of 10 contigs containing a total sequence of 4,484,902 bp with an N50 contig size of 2,911,226 bp. The genome assembly indicates the presence of a chromosome (trimmed) and three circular plasmids (untrimmed) in the SP1917 genome. Both genomes were annotated using the Analysis Engine at the University of Maryland (6). Analysis at the CGE server (http://www.cbs.dtu.dk/services) indicates that B11911 belongs to sequence type 149 (Pasteur), while SP1917 belongs to an unknown sequence type. ResFinder-2.1 analysis at CGE server confirms the presence of multiple resistance determinants against aminoglycosides, β-lactams, macrolide (and related antibiotics), chloramphenicol, rifampin, and sulfonamides antibiotics in the genomes. The analysis failed to identify any resistance genes against fluoroquinolone, fosfomycin, fusidic acid, glycopeptides, oxazolidinone, and trimethoprim in the genomes. However, SP1917 appears to encode a tetracycline resistance cassette (tetB), but no such resistance genes were found in B11911. As for the β-lactam resistance, SP1917 appears to harbor blaOXA-23, blaOXA-144, and blaNDM-1 alleles, whereas B11911 appears to harbor, in addition to blaOXA-23 and blaNDM-1, blaPER-7, and blaOXA-203 alleles. In both genomes we identified five putative secondary metabolite gene clusters (including acinetobactin and acinetoferrin) by antiSMASH (7), at least four genomic islands by IslandViewer3 (8), and multiple prophage sequences by PHAST analyses (9). The availability of these two MDR genome sequences will further facilitate comparative genomic analysis and evolutionary studies related to antibiotic resistance mechanisms in A. baumannii.

Nucleotide sequence accession numbers.

The draft genome sequences have been deposited in DDBJ/EMBL/GenBank under the accession numbers LFYX00000000 (B11911) and LFYW00000000 (SP1917). The versions described in this article are the first versions, LFYX00000000.1 and LFYW00000000.1, respectively.
  9 in total

1.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

Review 2.  Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.

Authors:  Michael J McConnell; Luis Actis; Jerónimo Pachón
Journal:  FEMS Microbiol Rev       Date:  2012-06-18       Impact factor: 16.408

3.  Real-time DNA sequencing from single polymerase molecules.

Authors:  John Eid; Adrian Fehr; Jeremy Gray; Khai Luong; John Lyle; Geoff Otto; Paul Peluso; David Rank; Primo Baybayan; Brad Bettman; Arkadiusz Bibillo; Keith Bjornson; Bidhan Chaudhuri; Frederick Christians; Ronald Cicero; Sonya Clark; Ravindra Dalal; Alex Dewinter; John Dixon; Mathieu Foquet; Alfred Gaertner; Paul Hardenbol; Cheryl Heiner; Kevin Hester; David Holden; Gregory Kearns; Xiangxu Kong; Ronald Kuse; Yves Lacroix; Steven Lin; Paul Lundquist; Congcong Ma; Patrick Marks; Mark Maxham; Devon Murphy; Insil Park; Thang Pham; Michael Phillips; Joy Roy; Robert Sebra; Gene Shen; Jon Sorenson; Austin Tomaney; Kevin Travers; Mark Trulson; John Vieceli; Jeffrey Wegener; Dawn Wu; Alicia Yang; Denis Zaccarin; Peter Zhao; Frank Zhong; Jonas Korlach; Stephen Turner
Journal:  Science       Date:  2008-11-20       Impact factor: 47.728

4.  The IGS Standard Operating Procedure for Automated Prokaryotic Annotation.

Authors:  Kevin Galens; Joshua Orvis; Sean Daugherty; Heather H Creasy; Sam Angiuoli; Owen White; Jennifer Wortman; Anup Mahurkar; Michelle Gwinn Giglio
Journal:  Stand Genomic Sci       Date:  2011-04-25

5.  PHAST: a fast phage search tool.

Authors:  You Zhou; Yongjie Liang; Karlene H Lynch; Jonathan J Dennis; David S Wishart
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

6.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

7.  Minimus: a fast, lightweight genome assembler.

Authors:  Daniel D Sommer; Arthur L Delcher; Steven L Salzberg; Mihai Pop
Journal:  BMC Bioinformatics       Date:  2007-02-26       Impact factor: 3.169

8.  antiSMASH 3.0-a comprehensive resource for the genome mining of biosynthetic gene clusters.

Authors:  Tilmann Weber; Kai Blin; Srikanth Duddela; Daniel Krug; Hyun Uk Kim; Robert Bruccoleri; Sang Yup Lee; Michael A Fischbach; Rolf Müller; Wolfgang Wohlleben; Rainer Breitling; Eriko Takano; Marnix H Medema
Journal:  Nucleic Acids Res       Date:  2015-05-06       Impact factor: 16.971

9.  IslandViewer 3: more flexible, interactive genomic island discovery, visualization and analysis.

Authors:  Bhavjinder K Dhillon; Matthew R Laird; Julie A Shay; Geoffrey L Winsor; Raymond Lo; Fazmin Nizam; Sheldon K Pereira; Nicholas Waglechner; Andrew G McArthur; Morgan G I Langille; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2015-04-27       Impact factor: 16.971

  9 in total
  2 in total

1.  Draft Genome Sequence of a Polymyxin B-Resistant Sequence Type 195 Clinical Isolate of Acinetobacter baumannii from India.

Authors:  Bina Agarwal; Niraj Agarwala; Sarangapani Saikia; Snigdha Sarkar; Giasuddin Ahmed
Journal:  Genome Announc       Date:  2018-02-08

2.  Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates.

Authors:  Saranya Vijayakumar; Sangeetha Rajenderan; Shakti Laishram; Shalini Anandan; Veeraraghavan Balaji; Indranil Biswas
Journal:  Front Public Health       Date:  2016-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.